Cutaneous Mastocytosis in Childhood-Update from the Literature

Overview

Journal J Clin Med

Specialty General Medicine

Date 2021 Apr 30

PMID 33918305

Citations 10

Authors

Florica Sandru

Razvan-Cosmin Petca

Monica Costescu

Mihai Cristian Dumitrascu

Adelina Popa

Aida Petca

Raluca-Gabriela Miulescu

Affiliations

Soon will be listed here.

Abstract

Mastocytosis (M) represents a systemic pathology characterized by increased accumulation and clonal proliferation of mast cells in the skin and/or different organs. Broadly, M is classified into two categories: Cutaneous mastocytosis (CM) and systemic mastocytosis (SM). In children, CM is the most frequent form. Unfortunately, pathogenesis is still unclear. It is thought that genetic factors are involved, but further studies are necessary. As for features of CM, the lesions differ in clinical forms. The most important fact is evaluating a pediatric patient with CM. It must comprise laboratory exams (with baseline dosing of total serum tryptase), a skin biopsy (with a pathological exam and, if the diagnosis is unclear, immunohistochemical tests), and a complete clinical evaluation. It is also defining to distinguish between CM and other diseases with cutaneous involvement. As for the management of CM in children, the first intervention implies eliminating trigger factors. The available cures are oral H1 and/or H2 antihistamines, oral cromolyn sodium, oral methoxypsoralen therapy with long-wave psoralen plus ultraviolet A radiation, potent dermatocorticoid, and calcineurin inhibitors. In children, the prognosis of CM is excellent, especially if the disease's onset is in the first or second years of life.

Citing Articles

A rare case of pediatric cutaneous bullous mastocytosis.

Roux J, Pham C, Yale K, Rojek N, Linden K, Doan L JAAD Case Rep. 2025; 57:14-17.

PMID: 39927220 PMC: 11803904. DOI: 10.1016/j.jdcr.2024.11.041.

Local Control of Advanced Breast Cancer-Debate in Multidisciplinary Tumor Board.

Pantelimon I, Stancu A, Coniac S, Ionescu A, Atasiei D, Georgescu D J Clin Med. 2025; 14(2).

PMID: 39860516 PMC: 11766072. DOI: 10.3390/jcm14020510.

Assessing the Impact of Organ Failure and Metastases on Quality of Life in Breast Cancer Patients: A Prospective Study Based on Utilizing EORTC QLQ-C30 and EORTC QLQ-BR45 Questionnaires in Romania.

Ionescu Miron A, Anghel A, Antone-Iordache I, Atasiei D, Anghel C, Barnonschi A J Pers Med. 2024; 14(2).

PMID: 38392647 PMC: 10889928. DOI: 10.3390/jpm14020214.

Diffuse Cutaneous Mastocytosis: A Current Understanding of a Rare Disease.

Rydz A, Lange M, Lugowska-Umer H, Sikorska M, Nowicki R, Morales-Cabeza C Int J Mol Sci. 2024; 25(3).

PMID: 38338679 PMC: 11154339. DOI: 10.3390/ijms25031401.

Crossroads between Skin and Endocrine Glands: The Interplay of Lichen Planus with Thyroid Anomalies.

Radu A, Carsote M, Nistor C, Dumitrascu M, Sandru F Biomedicines. 2024; 12(1).

PMID: 38255184 PMC: 10813575. DOI: 10.3390/biomedicines12010077.

References

Patnaik M, Rindos M, Kouides P, Tefferi A, Pardanani A . Systemic mastocytosis: a concise clinical and laboratory review. Arch Pathol Lab Med. 2007; 131(5):784-91. DOI: 10.5858/2007-131-784-SMACCA. View

Makkar H, Frieden I . Congenital melanocytic nevi: an update for the pediatrician. Curr Opin Pediatr. 2002; 14(4):397-403. DOI: 10.1097/00008480-200208000-00007. View

Kettelhut B, Metcalfe D . Pediatric mastocytosis. J Invest Dermatol. 1991; 96(3):15S-18S. View

Antiga E, Caproni M, Fabbri P . Linear immunoglobulin a bullous dermatosis: need for an agreement on diagnostic criteria. Dermatology. 2013; 226(4):329-32. DOI: 10.1159/000350818. View

Brockow K, Akin C, Huber M, Metcalfe D . IL-6 levels predict disease variant and extent of organ involvement in patients with mastocytosis. Clin Immunol. 2005; 115(2):216-23. DOI: 10.1016/j.clim.2005.01.011. View

Leung A, Lam J, Leong K . Childhood Solitary Cutaneous Mastocytoma: Clinical Manifestations, Diagnosis, Evaluation, and Management. Curr Pediatr Rev. 2018; 15(1):42-46. PMC: 6696819. DOI: 10.2174/1573396315666181120163952. View

Carter M, Metcalfe D . Paediatric mastocytosis. Arch Dis Child. 2002; 86(5):315-9. PMC: 1751103. DOI: 10.1136/adc.86.5.315. View

Uzzaman A, Maric I, Noel P, Kettelhut B, Metcalfe D, Carter M . Pediatric-onset mastocytosis: a long term clinical follow-up and correlation with bone marrow histopathology. Pediatr Blood Cancer. 2009; 53(4):629-34. PMC: 2786499. DOI: 10.1002/pbc.22125. View

Noack F, Escribano L, Sotlar K, Nunez R, Schuetze K, Valent P . Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL. Leuk Lymphoma. 2003; 44(2):313-9. DOI: 10.1080/1042819021000037967. View

10.

Worobec A, Akin C, Scott L, Metcalfe D . Cytogenetic abnormalities and their lack of relationship to the Asp816Val c-kit mutation in the pathogenesis of mastocytosis. J Allergy Clin Immunol. 1998; 102(3):523-4. DOI: 10.1016/s0091-6749(98)70144-7. View

11.

Cengizlier R, Hucumenoglu S, Ozen A, Tulin Sayli R . Treatment of telangiectasia macularis eruptiva perstans with montelukast. Allergol Immunopathol (Madr). 2009; 37(6):334-6. DOI: 10.1016/j.aller.2009.03.010. View

12.

Mitsumoto Y, Oka S, Sakuma H, Inazawa J, Kawasaki T . Cloning and chromosomal mapping of human glucuronyltransferase involved in biosynthesis of the HNK-1 carbohydrate epitope. Genomics. 2000; 65(2):166-73. DOI: 10.1006/geno.2000.6152. View

13.

Murphy M, Walsh D, Drumm B, Watson R . Bullous mastocytosis: a fatal outcome. Pediatr Dermatol. 2000; 16(6):452-5. DOI: 10.1046/j.1525-1470.1999.00116.x. View

14.

Fine J, Eady R, Bauer E, Bauer J, Bruckner-Tuderman L, Heagerty A . The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol. 2008; 58(6):931-50. DOI: 10.1016/j.jaad.2008.02.004. View

15.

Waterfield T, Dyer E, Wilson K, Boyle R . How to interpret mast cell tests. Arch Dis Child Educ Pract Ed. 2016; 101(5):246-51. DOI: 10.1136/archdischild-2015-309887. View

16.

Muller U, Helbling A, Hunziker T, Wuthrich B, Pecoud A, Gilardi S . Mastocytosis and atopy: a study of 33 patients with urticaria pigmentosa. Allergy. 1990; 45(8):597-603. DOI: 10.1111/j.1398-9995.1990.tb00945.x. View

17.

Slavkovic-Jovanovic M, Jovanovic D, Petrovic A, Mihailovic D . Urticaria pigmentosa. A case report. Acta Dermatovenerol Alp Pannonica Adriat. 2008; 17(2):79-82. View

18.

Bussmann C, Hagemann T, Hanfland J, Haidl G, Bieber T, Novak N . Flushing and increase of serum tryptase after mechanical irritation of a solitary mastocytoma. Eur J Dermatol. 2007; 17(4):332-4. DOI: 10.1684/ejd.2007.0210. View

19.

Pardanani A . Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management. Am J Hematol. 2018; 94(3):363-377. DOI: 10.1002/ajh.25371. View

20.

Hartmann K, Escribano L, Grattan C, Brockow K, Carter M, Alvarez-Twose I . Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology. J Allergy Clin Immunol. 2015; 137(1):35-45. DOI: 10.1016/j.jaci.2015.08.034. View